Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Free Cash Flow (2016 - 2026)

Summit Therapeutics filings provide 13 years of Free Cash Flow readings, the most recent being -$123.0 million for Q1 2026.

  • Quarterly Free Cash Flow fell 99.77% to -$123.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$385.0 million through Mar 2026, down 121.67% year-over-year, with the annual reading at -$323.6 million for FY2025, 127.49% down from the prior year.
  • Free Cash Flow hit -$123.0 million in Q1 2026 for Summit Therapeutics, down from -$102.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $5.2 million in Q4 2022 and bottomed at -$123.0 million in Q1 2026.
  • Average Free Cash Flow over 5 years is -$41.6 million, with a median of -$30.1 million recorded in 2024.
  • The largest annual shift saw Free Cash Flow surged 155.93% in 2022 before it crashed 474.18% in 2023.
  • Summit Therapeutics' Free Cash Flow stood at $5.2 million in 2022, then crashed by 474.18% to -$19.5 million in 2023, then tumbled by 150.82% to -$48.8 million in 2024, then plummeted by 109.17% to -$102.1 million in 2025, then decreased by 20.5% to -$123.0 million in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Free Cash Flow are -$123.0 million (Q1 2026), -$102.1 million (Q4 2025), and -$93.5 million (Q3 2025).